Adipocyte epigenetic alterations and potential therapeutic targets in transgenerationally inherited lean and obese phenotypes following ancestral exposures.
Stephanie E KingEric E NilssonDaniel BeckMichael K SkinnerPublished in: Adipocyte (2020)
The incidence of obesity has increased dramatically over the past two decades with a prevalence of approximately 40% of the adult population within the United States. The current study examines the potential for transgenerational adipocyte (fat cell) epigenetic alterations. Adipocytes were isolated from the gonadal fat pad of the great-grand offspring F3 generation 1-year old rats ancestrally exposed to DDT (dichlorodiphenyltrichloroethane), atrazine, or vehicle control in order to obtain adipocytes for DNA methylation analysis. Observations indicate that there were differential DNA methylated regions (DMRs) in the adipocytes with the lean or obese phenotypes compared to control normal (non-obese or lean) populations. The comparison of epigenetic alterations indicated that there were substantial overlaps between the different treatment lineage groups for both the lean and obese phenotypes. Novel correlated genes and gene pathways associated with DNA methylation were identified, and may aid in the discovery of potential therapeutic targets for metabolic diseases such as obesity. Observations indicate that ancestral exposures during critical windows of development can induce the epigenetic transgenerational inheritance of DNA methylation changes in adipocytes that ultimately may contribute to an altered metabolic phenotype.
Keyphrases
- adipose tissue
- dna methylation
- insulin resistance
- genome wide
- high fat diet
- gene expression
- weight loss
- high fat diet induced
- metabolic syndrome
- copy number
- bone mineral density
- risk factors
- type diabetes
- mitochondrial dna
- single cell
- air pollution
- bariatric surgery
- postmenopausal women
- high throughput
- cell free
- single molecule
- fatty acid
- human health
- physical activity
- circulating tumor
- bone marrow
- risk assessment
- obese patients